Modifiable lifestyle factors, genetic and acquired risk, and the risk of severe liver disease in the UK Biobank cohort (Lifestyle factors and SLD)

被引:2
作者
Liu, Zhening [1 ]
Huang, Hangkai [1 ]
Xie, Jiarong [1 ,2 ,3 ]
Shen, Qi-en [1 ]
Xu, Chengfu [1 ,3 ,4 ]
机构
[1] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Gastroenterol, Hangzhou 310003, Peoples R China
[2] Ningbo First Hosp, Dept Gastroenterol, Ningbo 315010, Peoples R China
[3] Zhejiang Prov Clin Res Ctr Digest Dis, Hangzhou 310003, Peoples R China
[4] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Gastroenterol, 79 Qingchun Rd, Hangzhou 310003, Peoples R China
基金
中国国家自然科学基金;
关键词
Lifestyle; Severe liver disease; Genetic susceptibility; Fibrosis; ASSOCIATION; MORTALITY; FIBROSIS; INDIVIDUALS;
D O I
10.1016/j.dld.2023.06.025
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Lifestyle intervention is important for the treatment of liver diseases.Aims: To clarify the association of healthy lifestyle with severe liver disease (SLD) and assessed whether genetic susceptibility and acquired fibrosis risk can modify the association.Methods: We included 417,986 UK Biobank participants who were free of SLD at baseline. Information on seven modifiable lifestyle factors was collected through a baseline questionnaire. SLD was defined as a medical diagnosis of cirrhosis, hepatocellular carcinoma or liver failure. Cox proportional hazards models were used to evaluate the association between healthy lifestyle factors and risk of incident SLD. The polygenic risk score (PRS) and fibrosis-4 index (FIB-4) were calculated and set as an interaction term.Results: During a median follow-up of 12.6 years, 4542 fatal and non-fatal SLD incidents were identified. A higher overall lifestyle score was associated with a significantly lower SLD risk (P-trend< 0.001). An increment of 1-point lifestyle score combined with a 1-SD increment in FIB-4 or PRS was associated with an additional reduction of 3% or 2% in SLD risk.Conclusions: In European individuals, a healthy lifestyle is associated with a lower risk of incident SLD, which is more pronounced among individuals with a higher genetic and fibrosis risk.(c) 2023 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:130 / 136
页数:7
相关论文
共 40 条
[1]   Social support and risk of mortality in cirrhosis: A cohort study [J].
Askgaard, Gro ;
Madsen, Lone Galmstrup ;
von Wowern, Natasja ;
Winther-Jensen, Matilde ;
Lau, Cathrine Juel ;
Christensen, Anne Illemann ;
Crooks, Colin ;
West, Joe ;
Jepsen, Peter .
JHEP REPORTS, 2023, 5 (01)
[2]   Burden of liver diseases in the world [J].
Asrani, Sumeet K. ;
Devarbhavi, Harshad ;
Eaton, John ;
Kamath, Patrick S. .
JOURNAL OF HEPATOLOGY, 2019, 70 (01) :151-171
[3]   The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population [J].
Bedogni, Giorgio ;
Bellentani, Stefano ;
Miglioli, Lucia ;
Masutti, Flora ;
Passalacqua, Marilena ;
Castiglione, Anna ;
Tiribelli, Claudio .
BMC GASTROENTEROLOGY, 2006, 6 (1)
[4]   Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies [J].
D'Amico, G ;
Garcia-Tsao, G ;
Pagliaro, L .
JOURNAL OF HEPATOLOGY, 2006, 44 (01) :217-231
[5]   Metabolic and genetic determinants for progression to severe liver disease in subjects with obesity from the UK Biobank [J].
De Vincentis, Antonio ;
Tavaglione, Federica ;
Spagnuolo, Rocco ;
Pujia, Roberta ;
Tuccinardi, Dario ;
Masciana, Gianluca ;
Picardi, Antonio ;
Incalzi, Raffaele Antonelli ;
Valenti, Luca ;
Romeo, Stefano ;
Vespasiani-Gentilucci, Umberto .
INTERNATIONAL JOURNAL OF OBESITY, 2022, 46 (03) :486-493
[6]   A Polygenic Risk Score to Refine Risk Stratification and Prediction for Severe Liver Disease by Clinical Fibrosis Scores [J].
De Vincentis, Antonio ;
Tavaglione, Federica ;
Jamialahmadi, Oveis ;
Picardi, Antonio ;
Incalzi, Raffaele Antonelli ;
Valenti, Luca ;
Romeo, Stefano ;
Vespasiani-Gentilucci, Umberto .
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (03) :658-673
[7]   Gene-lifestyle interaction on risk of type 2 diabetes: A systematic review [J].
Dietrich, Stefan ;
Jacobs, Simone ;
Zheng, Ju-Sheng ;
Meidtner, Karina ;
Schwingshackl, Lukas ;
Schulze, Matthias B. .
OBESITY REVIEWS, 2019, 20 (11) :1557-1571
[8]   Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver [J].
Dongiovanni, P. ;
Stender, S. ;
Pietrelli, A. ;
Mancina, R. M. ;
Cespiati, A. ;
Petta, S. ;
Pelusi, S. ;
Pingitore, P. ;
Badiali, S. ;
Maggioni, M. ;
Mannisto, V. ;
Grimaudo, S. ;
Pipitone, R. M. ;
Pihlajamaki, J. ;
Craxi, A. ;
Taube, M. ;
Carlsson, L. M. S. ;
Fargion, S. ;
Romeo, S. ;
Kozlitina, J. ;
Valenti, L. .
JOURNAL OF INTERNAL MEDICINE, 2018, 283 (04) :356-370
[9]   Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases [J].
Gines, Pere ;
Castera, Laurent ;
Lammert, Frank ;
Graupera, Isabel ;
Serra-Burriel, Miquel ;
Allen, Alina M. ;
Wong, Vincent Wai-Sun ;
Hartmann, Phillipp ;
Thiele, Maja ;
Caballeria, Llorenc ;
de Knegt, Robert J. ;
Grgurevic, Ivica ;
Augustin, Salvador ;
Tsochatzis, Emmanuel A. ;
Schattenberg, Jorn M. ;
Guha, Indra Neil ;
Martini, Andrea ;
Morillas, Rosa M. ;
Garcia-Retortillo, Montserrat ;
de Koning, Harry J. ;
Fabrellas, Nuria ;
Pich, Judit ;
Ma, Ann T. ;
Diaz, M. Alba ;
Roulot, Dominique ;
Newsome, Philip N. ;
Manns, Michael ;
Kamath, Patrick S. ;
Krag, Aleksander .
HEPATOLOGY, 2022, 75 (01) :219-228
[10]   Repeated FIB-4 measurements can help identify individuals at risk of severe liver disease [J].
Hagstrom, Hannes ;
Talback, Mats ;
Andreasson, Anna ;
Walldius, Goran ;
Hammar, Niklas .
JOURNAL OF HEPATOLOGY, 2020, 73 (05) :1023-1029